According to an announcement on the official website of Ispire on January 4th, the company has declared that its Malaysian subsidiary, Ispire Malaysia Sdn Bhd, has successfully obtained certifications for ISO9001:2015 Quality Management System, ISO14001:2015 Environmental Management System, and ISO13485:2016 Medical Device Quality Management System for its manufacturing facility in Malaysia.
Michael Wang, the CEO of the company, stated that having our own factory will allow us to achieve greater profits in product assembly. Furthermore, the products produced by our company in Malaysia and shipped to the United States are not affected by tariffs, which creates favorable conditions for increasing gross profit margins.
Michael Wang stated, "We have received our initial orders and are rapidly entering the production preparation phase. By establishing production facilities in Malaysia, we not only avoid the 25% tariffs incurred from shipping from China, but also improve our gross profit margin."
In order to reduce tariff costs, it is predicted that Ispire will further shift its production processes to Malaysia.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
